Global Amifostine Market Growth 2023-2029

Global Amifostine Market Growth 2023-2029

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
LPI (LP Information)' newest research report, the “Amifostine Industry Forecast” looks at past sales and reviews total world Amifostine sales in 2022, providing a comprehensive analysis by region and market sector of projected Amifostine sales for 2023 through 2029. With Amifostine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amifostine industry.
This Insight Report provides a comprehensive analysis of the global Amifostine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amifostine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Amifostine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amifostine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amifostine.
The global Amifostine market size is projected to grow from US$ 49 million in 2022 to US$ 57 million in 2029; it is expected to grow at a CAGR of 57 from 2023 to 2029.
Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Amifostine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
400mg/Dose
500mg/Dose
Segmentation by application
Head and Neck Cancer Adjuvant Therapy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Amifostine market?
What factors are driving Amifostine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amifostine market opportunities vary by end market size?
How does Amifostine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.